Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C21H21Cl3N4O |
| Molecular Weight | 451.777 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
ClC1=CC=C(C=C1)C2CC(=NN2C3=CC=C(Cl)C=C3Cl)C(=O)NN4CCCCC4
InChI
InChIKey=WMMMJGKFKKBRQR-UHFFFAOYSA-N
InChI=1S/C21H21Cl3N4O/c22-15-6-4-14(5-7-15)20-13-18(21(29)26-27-10-2-1-3-11-27)25-28(20)19-9-8-16(23)12-17(19)24/h4-9,12,20H,1-3,10-11,13H2,(H,26,29)
| Molecular Formula | C21H21Cl3N4O |
| Molecular Weight | 451.777 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Rosonabant (E-6776) is a CB1-receptor antagonist that has appetite suppressant activity and was under development for the treatment of obesity. This preclinical anti-obesity drug shows activity that is similar to romonabant, a drug that was withdrawn from the European market due to severe side effects such as nausea, depression and suicidal ideations. Drug development of rosonabant has subsequently been halted.
Originator
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:43:40 GMT 2025
by
admin
on
Mon Mar 31 18:43:40 GMT 2025
|
| Record UNII |
7X5RY2T485
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29728
Created by
admin on Mon Mar 31 18:43:40 GMT 2025 , Edited by admin on Mon Mar 31 18:43:40 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
300000036917
Created by
admin on Mon Mar 31 18:43:40 GMT 2025 , Edited by admin on Mon Mar 31 18:43:40 GMT 2025
|
PRIMARY | |||
|
11316914
Created by
admin on Mon Mar 31 18:43:40 GMT 2025 , Edited by admin on Mon Mar 31 18:43:40 GMT 2025
|
PRIMARY | |||
|
DTXSID201006613
Created by
admin on Mon Mar 31 18:43:40 GMT 2025 , Edited by admin on Mon Mar 31 18:43:40 GMT 2025
|
PRIMARY | |||
|
861151-12-4
Created by
admin on Mon Mar 31 18:43:40 GMT 2025 , Edited by admin on Mon Mar 31 18:43:40 GMT 2025
|
PRIMARY | |||
|
7X5RY2T485
Created by
admin on Mon Mar 31 18:43:40 GMT 2025 , Edited by admin on Mon Mar 31 18:43:40 GMT 2025
|
PRIMARY | |||
|
Rosonabant
Created by
admin on Mon Mar 31 18:43:40 GMT 2025 , Edited by admin on Mon Mar 31 18:43:40 GMT 2025
|
PRIMARY | |||
|
8616
Created by
admin on Mon Mar 31 18:43:40 GMT 2025 , Edited by admin on Mon Mar 31 18:43:40 GMT 2025
|
PRIMARY | |||
|
C90659
Created by
admin on Mon Mar 31 18:43:40 GMT 2025 , Edited by admin on Mon Mar 31 18:43:40 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> INHIBITOR |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|